๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

A Novel Alkylating Agent, Glufosfamide, Enhances the Activity of Gemcitabine In Vitro, In Vivo

โœ Scribed by Ammons, W. Steve; Wang, Jin-Wei; Yang, Zhijian; Tidmarsh, George F.; Hoffman, Robert M.

Book ID
122268501
Publisher
Neoplasia Press
Year
2007
Tongue
English
Weight
421 KB
Volume
9
Category
Article
ISSN
1522-8002

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Etoposide with lonidamine or pentoxifyll
Etoposide with lonidamine or pentoxifylline as modulators of alkylating agent activity in vivo
โœ Juichi Tanaka; Beverly A. Teicher; Terence S. Herman; Sylvia A. Holden; Bruce De ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 857 KB

In an effort to improve the additive anti-tumor efficacy of commonly used alkylating agents, the topoisomerase-ll inhibitor etoposide was used in combination with either the mitochondrial poison and energy-depleting agent lonidamine or the hemorheologic agent and tumor-blood-flow-increasing agent pe

Resveratrol, a multitargeted agent, can
Resveratrol, a multitargeted agent, can enhance antitumor activity of gemcitabine in vitro and in orthotopic mouse model of human pancreatic cancer
โœ Kuzhuvelil B. Harikumar; Ajaikumar B. Kunnumakkara; Gautam Sethi; Parmeswaran Di ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 1006 KB

## Abstract Gemcitabine, while a standard treatment of advanced pancreatic cancer (PaCa), alone is not very effective. New agents that are safe and effective are highly needed. Resveratrol is one such agent which is safe and multitargeted; and has been linked with suppression of survival, prolifera